Tatsu Shimoyama Selected Research

Tatsu Shimoyama Research Topics

Disease

16	Neoplasms (Cancer) 03/2023 - 08/2005
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 12/2015
4	Lung Neoplasms (Lung Cancer) 03/2016 - 11/2005
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 08/2023 - 10/2017
3	Lymphoma (Lymphomas) 01/2023 - 12/2015
3	Stomach Neoplasms (Stomach Cancer) 11/2022 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 05/2019 - 03/2009
3	Neutropenia 05/2019 - 02/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2005 - 02/2002
2	Anemia 08/2023 - 11/2011
2	Hypoalbuminemia 08/2023 - 04/2018
2	Thrombocytopenia (Thrombopenia) 08/2023 - 10/2005
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 08/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 01/2014
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2020 - 06/2015
2	Headache (Headaches) 09/2019 - 11/2006
2	Neoplasm Metastasis (Metastasis) 09/2019 - 03/2009
2	Nausea 09/2019 - 05/2011
2	Disease Progression 05/2019 - 11/2006
2	Breast Neoplasms (Breast Cancer) 03/2016 - 09/2006
2	Diarrhea 05/2011 - 11/2006
2	Hypertension (High Blood Pressure) 07/2009 - 11/2006
1	Frailty 06/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023
1	Adenocarcinoma 01/2023
1	Febrile Neutropenia 03/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021
1	COVID-19 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Neuroendocrine Carcinoma 08/2020
1	Pancytopenia 06/2020
1	Glioblastoma (Glioblastoma Multiforme) 06/2020
1	Leukemia 05/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2019
1	Choriocarcinoma 09/2019
1	Brain Neoplasms (Brain Tumor) 09/2019
1	Hemorrhage 09/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2019
1	Triple Negative Breast Neoplasms 09/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2018

Drug/Important Bio-Agent (IBA)

6	Rituximab (Mabthera)FDA Link 01/2024 - 12/2017
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 11/2005
4	Fluorouracil (Carac)FDA LinkGeneric 03/2023 - 09/2006
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2023 - 07/2009
3	Chimeric Antigen ReceptorsIBA 01/2023 - 11/2021
2	Gemcitabine FDA Link 03/2023 - 02/2002
2	Leucovorin (Folinic Acid)FDA Link 03/2023 - 05/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2023 - 07/2006
2	Bendamustine Hydrochloride FDA Link 01/2023 - 03/2021
2	PlatinumIBA 01/2023 - 08/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2022 - 09/2006
2	Bevacizumab (Avastin)FDA Link 05/2019 - 03/2009
2	Phosphotransferases (Kinase)IBA 09/2018 - 05/2011
2	AlbuminsIBA 04/2018 - 05/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2018 - 10/2016
2	Biomarkers (Surrogate Marker)IBA 05/2011 - 11/2005
2	orantinib (SU6668)IBA 05/2011 - 05/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2011 - 05/2011
2	Tyrosine Kinase InhibitorsIBA 03/2008 - 07/2006
2	Alanine Transaminase (SGPT)IBA 11/2006 - 12/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2006 - 12/2003
2	Gefitinib (Iressa)FDA Link 07/2006 - 08/2005
2	Cisplatin (Platino)FDA LinkGeneric 12/2003 - 02/2002
1	Oxidoreductases (Dehydrogenase)IBA 08/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	folfirinoxIBA 03/2023
1	130-nm albumin-bound paclitaxelIBA 03/2023
1	polatuzumab vedotinIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	AntigensIBA 11/2022
1	Vincristine (Oncovin)FDA LinkGeneric 03/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022
1	pegfilgrastim (Neulasta)FDA Link 03/2022
1	Prednisone (Sone)FDA LinkGeneric 03/2022
1	tisagenlecleucelIBA 01/2022
1	amrubicinIBA 08/2020
1	Epstein-Barr virus encoded RNA 1IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 09/2019
1	bosutinibIBA 05/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018
1	Folic Acid AntagonistsIBA 10/2017
1	10-propargyl-10-deazaaminopterin FDA Link 10/2017

Therapy/Procedure

15	Therapeutics 01/2024 - 11/2006
14	Drug Therapy (Chemotherapy) 09/2023 - 02/2002
3	Neoadjuvant Therapy 09/2018 - 09/2006
2	Stem Cell Transplantation 11/2021 - 09/2018
1	Aftercare (After-Treatment) 03/2023
1	Autologous Transplantation 11/2021
1	Salvage Therapy 08/2020
1	Chemoradiotherapy 06/2020
1	Hematopoietic Stem Cell Transplantation 12/2019
1	Craniotomy 09/2019
1	Radiotherapy 09/2019
1	Combined Modality Therapy 09/2019
1	Renal Dialysis (Hemodialysis) 05/2019
1	Drug Tapering 05/2019